Lexeo Therapeutics (LXEO) Current Taxes (2022 - 2024)

Lexeo Therapeutics (LXEO) reported Current Taxes of $36000.0 for Q2 2024, down 76.0% sequentially from $150000.0 in Q1 2024.

Lexeo Therapeutics (LXEO) Current Taxes (2022 - 2024) Analysis & Trends

Lexeo Therapeutics (LXEO) has 3 years of Current Taxes data on file, last reported at $36000.0 in Q2 2024.

  • For the quarter ending Q2 2024, Current Taxes changed N/A year-over-year to $36000.0; the trailing twelve-month figure through Jun 2024 stood at $36000.0 (changed N/A YoY), and the FY2023 full-year result was $157000.0, down 68.97% from the prior year.
  • Current Taxes declined to $36000.0 in Q2 2024, from $150000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $506000.0 in Q4 2022 to a low of $16000.0 in Q3 2023.
  • A 3-year average of $173000.0 and a median of $150000.0 in 2024 frame the typical range for Current Taxes.
  • Peak annual rise in Current Taxes reached 68.97% in 2023, while the deepest fall reached 68.97% in 2023.
  • Tracing LXEO's Current Taxes over 3 years: stood at $506000.0 in 2022, then tumbled by 68.97% to $157000.0 in 2023, then plunged by 77.07% to $36000.0 in 2024.
  • Business Quant data shows LXEO's Current Taxes at $36000.0 in Q2 2024, $150000.0 in Q1 2024, and $157000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 63.52 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 49.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Lexeo Therapeutics 382.38 Mn 382.38 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 36,000.00
Mar 31, 2024 150,000.00
Dec 31, 2023 157,000.00
Sep 30, 2023 16,000.00
Dec 31, 2022 506,000.00